🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study objective is to confirm appropriate use and safety profile of Pra...
Status
Completed
Location
Nippon Boehringer Ingelheim Co., Ltd
Start Date
2017-07-05
Trial ID
NCT03175198
Treatments Being Tested
A phase III, randomised, parallel-group, double-blind, active controlled st...
Status
Completed
Location
1160.25.06108 Boehringer Ingelheim Investigational Site
Start Date
2004-11
Trial ID
NCT00168805
Treatments Being Tested
The efficacy and safety of anticoagulation therapy using dabigatran in comp...
Status
Unknown
Location
Research Institute for Complex Problems of Cardiovascular Diseases
Start Date
2016-06-29
Trial ID
NCT03183843
Treatments Being Tested
This is a study to investigate biomarkers after single oral doses of the an...
Status
Completed
Location
Multiple Locations
Start Date
2011-05
Trial ID
NCT01379300
Treatments Being Tested
The objective of the current study is to investigate safety, tolerability a...
Status
Completed
Location
Multiple Locations
Start Date
2009-10
Trial ID
NCT02171572
Treatments Being Tested
To assess the steady state pharmacokinetic profile of BIBR 953 ZW after adm...
Status
Completed
Location
Multiple Locations
Start Date
2002-11
Trial ID
NCT02173730
Treatments Being Tested
The general aim of this study is to determine the comparative safety and ef...
Status
Completed
Location
1160.47.01035 Boehringer Ingelheim Investigational Site
Start Date
2006-05
Trial ID
NCT00329238
Treatments Being Tested
The purpose of this study is to investigate the one-way drug-drug interacti...
Status
Completed
Location
Worldwide Clinical Trials
Start Date
2020-08-28
Trial ID
NCT04459585
Treatments Being Tested
The goal of this study is to evaluate the comparative efficacy and safety o...
Status
Completed
Location
1160.50.001 Boehringer Ingelheim Investigational Site
Start Date
2005-10
Trial ID
NCT00246025
Treatments Being Tested
According to published studies, the effects of genetic polymorphisms in the...
Status
Unknown
Location
Multiple Locations
Start Date
2024-05-01
Trial ID
NCT06387407
Treatments Being Tested